Introduction
A critical arm of cellular adaptive immunity is the specific recognition of antigen presentation molecules on the surface of antigen presenting cells (APCs) by receptors on the surface of T-cells (TCRs). The major family of antigen presenting molecules, known as Major Histocompatibility Complex (MHC) Class I and Class II molecules, present peptidic antigens (Ag) for TCR recognition. In addition, MHC Class I like molecules, known as MR1 (Birkinshaw et al., 2014) and Cluster of Differentiation 1 (CD1) molecules (Beckman et al., 1994) , have the ability to present small metabolite and lipid-based antigens respectively. Whereas MHC Class I and II molecules are highly polymorphic, CD1 molecules exist as a single copy of each isoform in humans, and are presented on a range of APC's; predominantly myeloid dendritic cells (DCs) and macrophages (Brigl and Brenner, 2004) , as well as epidermal Langerhans cells (CD1a) (Pena-Cruz et al., 2003) , and marginal B cells (CD1c) (Smith et al., 1988) .
Human CD1 molecules are segmented into three groups, based on sequence identity and function, denoted as Group 1 (CD1a, CD1b, CD1c), Group 2 (CD1d), and Group 3 (CD1e), where they vary in mechanisms of intracellular trafficking, and tissue localization (Calabi and Milstein, 1986; Krutzik et al., 2005; Dougan et al., 2007; Schenk et al., 2012) . These molecules have been shown to present lipid antigens on the surface of APCs in humans (Bendelac et al., 2007; Rossjohn et al., 2015; Mori et al., 2016) , for the presentation of antigens towards T cells expressing cell surface αβ TCRs (Brigl and Brenner, 2004) , and γδ TCRs (Leslie et al., 2002; Luoma et al., 2013; Uldrich et al., 2013) . The exception lies with CD1e, which is constrained to the cytosol, and assists in the loading and processing of lipid antigens into CD1b (de la Salle et al., 2005; Garcia-Alles et al., 2011a) .
CD1 molecules exhibit a classical MHC Class-I like fold; comprised of the CD1 glycoprotein heavy chain exhibiting three domains (α1-α3), which is stabilized by formation of a non-covalently linked heterodimer with β-2 microglobulin (β2 m). This generates a stable antigen binding cleft between the α1 and α2 domains that forms a highly hydrophobic cavity ideal of lipid antigen presentation. CD1 molecules vary drastically in their antigen binding groove architecture and size, where CD1a ) exhibit the capacity to present a wide array of lipid antigens.
CD1 molecules are conserved through evolution, and are present in a range of mammalian species, with the exception of murine species, with only CD1d expressed in mice . As such, much of the research to date has been conducted on CD1d, due to the success of its native mouse model. While significant advances in our understanding of CD1 biology has been attributed to the success of the native mouse model of CD1d, the subsequent lack of group 1 CD1s in murine species signifies an evident difference in biological function and lipid antigen presentation role between mice and humans (Le Nours et al., 2017) . The establishment of tetramer technology, and the recent generation of a double transgenic mouse model expressing Group 1 CD1 molecules (Bagchi et al., 2016 (Bagchi et al., , 2017 , has seen a rapid explosion in our understanding into their role in disease, TCR recognition, and T-cell responses (Reviewed in Rossjohn et al., 2015; Le Nours et al., 2017; Gras et al., 2018) .
It has become evident that Group 1 CD1s play a critical role in the presentation of lipid antigens in various disease state, including from microbial sources, such as M. tuberculosis (TB) (Beckman et al., 1994; Gilleron et al., 2004; Krutzik et al., 2005; Kasmar et al., 2011; van Rhijn et al., 2013; Gras et al., 2016) , bee and snake venom (Bourgeois et al., 2015; Subramaniam et al., 2016) , contact sensitizers from poison ivy (Kim et al., 2016) , as well as tumor specific lipids (Lepore et al., 2014; Bagchi et al., 2016) . CD1b itself was originally found to play a critical role in the presentation of exogenous TB antigens, and its role in disease has become well established; however only recently has its role in selfantigen presentation being explored, which has been implicated in autoimmunity and disease (Shamshiev et al., 1999 (Shamshiev et al., , 2000 Li et al., 2011; Bagchi et al., 2016 Bagchi et al., , 2017 Shahine et al., 2017) . Here, the available data exploring the self-lipid repertoire presented by CD1b, and the molecular mechanisms of CD1b presentation of self-lipid antigens are reviewed, as well as exploring the mode of recognition of CD1b by autoreactive TCRs.
CD1 trafficking and Gene regulation
Upon translation in the endoplasmic reticulum, CD1s are loaded with a mixture of polar and non-polar endogenous lipids, and exported to the cell surface of APCs (Briken et al., 2002; Brigl and Brenner, 2004) . Despite being loaded with a variety of endogenous lipids upon translation, the role of these lipids may not be involved in T cell recognition. Moreover, their initial function is to stabilize the CD1 architecture upon de novo translation and translocation to the cell surface. Here, CD1 molecules differ in their mechanism of intracellular trafficking through the endocytic pathway and targeted antigen capture; where CD1 molecules are recycled either at the cell surface (CD1a), early endosomes (CD1a and CD1c), or late endosome-lysosomes (CD1b and CD1d), based on the presence of cytoplasmic targeting sequences, binding to adaptor protein complex chaperones via recognition of targeted tyrosine signalling motifs, and the correlation of acidic pH requirement for antigen loading (Brigl and Brenner, 2004; Moody and Cotton, 2017) .
As CD1 molecules loaded with endogenous lipids are primarily trafficked to the cell surface for presentation, the question arises into the modes of T cell recognition of self-lipids: If CD1 molecules present endogenous lipids upon translation, what are the mechanisms for regulating T cell autoreactivity? While the understanding pertaining to this are broadly lacking for group 1 CD1 restricted T cells, the answers may lie in the interconnected mechanisms of gene regulation of CD1 expression in a disease state.
Expression of CD1 molecules are tightly regulated on specific subsets of thymocytes; contrasting with pMHC molecules that can be either ubiquitously expressed on the cell surface (Class I) or on a range thymocytes subsets (Class II), such as DCs, phagocytes, and epithelial cells . While the full mechanisms pertaining to transcriptional regulation are yet to be elucidated, Group 1 CD1 molecules, in particular CD1b, have been found to be inducibly expressed upon upregulation innate immune responses via Toll-Like Receptor 2 (TLR-2) in response to TB infection (Roura-Mir et al., 2005) . Furthermore, downstream cytokine responses from granulocyte-macrophage colony-stimulating factor (GM-CSF) (Porcelli et al., 1989) and IL-1β (Yakimchuk et al., 2011) have been found to stimulate development of immature DCs, which in turn induces cell surface antigen presentation by Group 1 CD1s, either upon bacterial infection (Roura-Mir et al., 2005; Yakimchuk et al., 2011) , or even with self-lipids (Leslie et al., 2008) . These immature DCs have the capacity to present CD1 molecules on the cell surface, that have a high propensity to activate CD1-restricted T cells (Leslie et al., 2008) .
While the mechanisms that drive Group 1 CD1 presentation of selflipid antigens has gained traction in recent years, there is still much that remains unknown on the mechanisms that regulate Group 1 CD1 gene regulation; emphasising the need for further characterization into what factors drive DC maturation in the context of CD1 expression and antigen presentation. Furthermore, there has been speculated that due to known tight regulation of Group 1 CD1 molecules, namely CD1b, mere surface expression may play as significant a role as the presence of lipid antigens in eliciting an immune response (Moody and Cotton, 2017) . As self-lipids have been found to induce DC maturation in the context of Group 1 CD1 molecules (Brigl and Brenner, 2004; Leslie et al., 2008) , further exploration into the characterization and role of self-lipid presentation by Group 1 CD1s, and how these influence downstream immunological processes, such as positive thymic selection and activation of CD1 + autoreactive T cells, is required.
CD1b self-antigen repertoire
Mammalian cells routinely synthesise a broad variety of self-lipids, such as phospholipids and sphingolipids, that are common constituents of cellular membranes; playing roles in cellular integrity, cell signalling, and as precursors in biosynthetic pathways. Due to the lipid binding capabilities of CD1 molecules, it is unsurprising to find many of these self-lipids as common constituents of the endogenous lipid repertoire bound within antigen binding clefts of CD1s upon translation. In fact, it is essential for CD1 to bind members of the endogenous lipid to maintain structural integrity of the protein; with downstream roles in presentation in a homeostatic state, and an expanding amount of evidence pointing towards self-lipid presentation in various disease states.
Phospholipids
Endogenous lipids in APCs include common membrane glycerophospholipids (denoted as phospholipids hereon), such as phosphatidylcholine (PC), phosphatidylethanolamine (PE), and phosphatidylinositol (PI), which have been eluted from each CD1 isoforms via mass spectroscopy (Park et al., 2004; Garcia-Alles et al., 2006; Huang et al., 2011) . Phospholipids are defined by a polar phosphate headgroup conjugated to a glycerol moiety, and exhibit either one (lyso-) or two (diacyl-) hydrophobic acyl lipid tails esterified to the glycerol moiety at the sn1 and sn2 positions. Phospholipid classes are grouped based on their phosphate headgroup moiety, which range in size, stereochemistry, and charge; with each species exhibiting a phosphatidic acid (PA) core (Fig. 1) .
Upon translation, CD1b is loaded with constituents of the endogenous lipid repertoire, such as PC and PE, which comprise approximately ∼10-15% of the lipid dry weight in APCs , for cell surface presentation. Furthermore, CD1b has the capabilities of presenting less common phospholipid species, such as the phosphatidylserine (PS), phosphatidylglycerol (PG), and phosphatidic acid (PA); that exhibit either a serine, glycerol, or no polar moiety respectively beyond the phosphate headgroup (van Rhijn et al., 2016; Shahine et al., 2017) (Fig. 1) . PG is relatively scarce in mammalian Structures of lipids bound by CD1b, grouped by Presented Lipids (upper) or Scaffold lipids (lower), which are generally bound in the A′ and C′ pockets, and T′ and F′ pockets respectively. Dashed line indicates divide between the polar headgroup (head) and hydrophobic core (tail). Abbreviations: Phosphatidylethanolamine (PE), phosphatidylglycerol (PG), phosphatidylserine (PS), phosphatidylcholine (PC), phosphatidylinositol (PI), phosphatidic acid (PA), lyso-phosphatidic acid (LPA), lysophosphatidylethanolamine (LPE), lyso-phosphatidylcholine (LPC), ether phosphatidylcholine (ePC), ether phosphatidylethanolamine (ePE), ether lyso-phosphatidylethanolamine (eLPE), sphingomyelin (SM), mono-sialogangloside (GM1), ganglioside M2 (GM2), ganglioside D1a (GD1a), ganglioside D1b (GD1b), and ganglioside G1b (GQ1b). cells, comprising approximately ∼1% of total lipid dry weight in APCs , which is predominantly localized within mammalian mitochondria; where it acts as precursor molecule in cardiolipin synthesis (Horvath and Daum, 2013; Morita and Terada, 2015) .
Since many of these lipids are commonly eluted from the endogenous lipid repertoire of CD1b, it is not currently known whether presentation post translation is sufficient to activate T cells, or if recycling through the endocytic pathway to load phospholipid antigens is required for presentation to T cells. It is known that lipid transfer proteins are required for loading of PS into CD1d in the endocytic pathway (Zhou et al., 2004) , however whether a similar mechanism for phospholipid loading into CD1b upon endosomal recycling requires further investigation.
Emerging data demonstrates that phospholipid antigen classes presented by CD1b extend beyond typical diacylated membrane phospholipids. These include lyso-phospholipids (Leslie et al., 2008) , and ether-linked plasmalogens (Bagchi et al., 2016 (Bagchi et al., , 2017 . Lyso-phospholipids exhibit a single acyl tail at the sn1-glycerol neck position, while retaining the aforementioned polar phosphor headgroups (Fig. 1) . Presentation and T cell activation have been demonstrated against CD1b, as well as other Group 1 CD1 members, of lyso-phosphatidylethanolamine (LPE), lyso-phosphatidylcholine (LPC), and lyso-phosphatidic acid (LPA) ( Fig. 1) (Lepore et al., 2014; Birkinshaw et al., 2015; Bagchi et al., 2016 Bagchi et al., , 2017 . On the other hand, plasmalogens exhibit an ether linked acyl tail at the sn1 position, as opposed to an ester linked acyl tail with typical phospholipids (Fig. 1) . Plasmalogens are the most abundant form of ether-phospholipids, contributing to approximately ∼ 15-20% of total phospholipid weight in human cells (Braverman and Moser, 2012) ; where they predominantly exhibit either a phosphoethanolamine or phosphocholine headgroup moiety ( Fig. 1 ) (Paltauf, 1994) . Both lysophospholipids and plasmalogens have been found to be relevant in T cell activation upon presentation by CD1b, and suggest they may be involved in the pathogenesis of psoriasis-like skin inflammation, and anti-tumor activity (discussed in Section 3.1) (Bagchi et al., 2016 (Bagchi et al., , 2017 .
Sphingolipids
Sphingolipids differ from phospholipids in structure, cellular membrane and tissue distribution, and function. While phospholipids are common cellular membrane constituents, sphingolipids predominantly reside in membrane lipid rafts, where they play key roles in cell adhesion and cellular signalling (Munro, 2003) . These lipids are characterized as exhibiting a sphingosine unit amine linked to an acyl tail, with sphingolipid classes including sphingomyelins (SM), sulfatides, ceramides, and gangliosides ( Fig. 1 ). SM and sulfatides exhibit either a phosphate or sulphate polar headgroup respectively, with SM sharing the same phosphocholine headgroup as PC (Fig. 1 ). Binding and presentation of both SM and sulfatides have been demonstrated by CD1 molecules (Zajonc et al., 2003; Patel et al., 2012; Luoma et al., 2013; Birkinshaw et al., 2015) , with sulfatides demonstrating promiscuity in CD1 presentation; where each Group 1 CD1 molecule loaded with sulfatide each have the capacity to activate their respective CD1-restricted T cell clones (Shamshiev et al., 2002) .
Gangliosides contain the same hydrophobic core as SM and sulfatide, however they exhibit complex oligosaccharide polar headgroups. While phospholipids are ubiquitous throughout mammalian tissues, ganglioside are generally enriched in myelin neuronal tissue and the thymus. Ganglioside GM1, also known as monosialo-ganglioside, comprises of a four-monosaccharide chain with a branched a sialic acid, or N-acetyl-β-D-galactosamine, saccharide (Fig. 1) , and was amongst the first self-lipid antigens identified to induce an autoreactive T cell response upon presentation by CD1b (Shamshiev et al., 1999) .
Further expansion into CD1b presentation of gangliosides revealed the capabilities to bind a host of gangliosides, including GM2, GD1a and GD1b, and GQ1b; with oligosaccharide headgroups ranging from 4 to 8 sugars (Shamshiev et al., 2000) . These gangliosides differ in the number, and positioning, of sialic group oligosaccharides, or in the case of GM2, the lack the distal galactose subunit (Fig. 1) . Furthermore, due to the complex, polar nature of their polysaccharide headgroups, it was found that antigen recycling into CD1b could occur extracellular on the cell surface, without the need to internalisation through the endocytic pathway (Shamshiev et al., 1999 (Shamshiev et al., , 2000 .
CD1b autoreactivity
CD1b has been established to play a critical role in the mediation of infection by TB, with the TB specific lipids mycolic acid and glucose monomycolate (GMM) being the first bacterial lipid antigens presented by CD1b identified (Beckman et al., 1994; Moody et al., 1997) . Only recently is evidence mounting for the role of surface self-lipid presentation by CD1b in the context of bacterial infection, autoimmunity, cellular stress, and cancer.
Role of self-lipid presentation by CD1b in disease
As a means of expanding the repertoire of bacterial lipid antigens, recently isolated double-negative (CD4 − CD8 − ) T-cells reactive towards CD1b presenting bacterial extract from Salmonella, Staphylococcus, and Brucella species were identified, where the self-lipid PG, as opposed to unique bacterial lipids, was identified as the immunodominant antigen . These T cell clones exhibited a similar level of activation towards PG, irrespective of the degree of unsaturation, methylation, or the presence of additional hydrophobic moieties found in predominant bacterial PG species . This indicated that recognition of the phosphoglycerol headgroup, as opposed to the properties of lipid anchors, was central to PG recognition upon presentation by CD1b; which was demonstrated upon structural determination of CD1b presenting PG in complex with the autoreactive TCR, PG90 . The presentation of the self PG antigen by CD1b implicates a role in either bacterial infection, or in autoimmunity; where PG is available for loading into CD1b under conditions of cellular or mitochondrial stress or damage . Furthermore, phospholipids PS, PI, and PA, were found to induce T cell activation, to a lesser extent compared to PG, with binding demonstrated both in vivo , and in vitro .
CD1b presentation of phospholipid antigens have further implicated its role in both autoimmune disease and cancer, through the advent of a double-transgenic mouse model expressing human group 1 CD1 molecules, as well as CD1b autoreactive HJ1 T cells. HJ1 T cells are activated by CD1b presenting a range of phospholipids, namely PC and PE, LPC and LPE, as well as plasmalogen ePC (Bagchi et al., 2016 (Bagchi et al., , 2017 (Fig. 1) . These lipids accumulate in a hyperlipidic disease state, where enhanced IL-6 and IL-17 A secretion is observed by CD1b presenting APCs and HJ1 T cells respectively, promoting psoriasis-like skin inflammation (Bagchi et al., 2017) . Furthermore, accumulation of these self-phospholipids, as well as PI and eLPE (Fig. 1) , are observed in tumours, where CD1b presentation elicited in vivo anti-tumour immunological responses (Bagchi et al., 2016) . It was found that HJ1 T cells responded more potently to phospholipids derived from tumor cells compared to normal cells in homeostasis, where the autoreactivity as enhanced in the presence of TLR agonists, and by CD1b + DC IL-12 secretion (Bagchi et al., 2016) . Aside from phospholipid antigens, presentation of self-sphingolipids by CD1b to T cells may play a role in the mediation of autoimmune diseases. CD1b restricted presentation of the sphingolipids, gangliosides and sulfatides (Fig. 1) , have been found to activate autoreactive T cells, with varying antigen specificities, isolated from patients with multiple sclerosis (MS) (Shamshiev et al., 1999) . GM1 was one of the first selflipid antigens identified to induce an autoreactive T cell response upon presentation by CD1b; where preferential activation occurred against GM1 over gangliosides exhibiting smaller headgroups, such as GM2 (Fig. 1) . On the other hand, T cell activation was maintained in the presentation of gangliosides exhibiting larger 5-8 oligosaccharide headgroups (Shamshiev et al., 1999; 2000; . Furthermore, T cell activation was abated in the presence of single tail gangliosides, or gangliosides with lipid tails larger that 18 carbons, suggesting both acyl and sphingosine units of the correct length were required for correct anchoring into CD1b (further discussed in Section 4.1) (Shamshiev et al., 2000) . Immunodominant ganglioside presentation resulted in activation of T cell clones isolated from MS patients through the release of interferon-γ (IFN-γ) and tumor necrosis factor α (TNF-α), which are indicative of a pro-inflammatory response in the disease state (Shamshiev et al., 1999) , and suggests a prevalent role for the pathogenesis for MS.
Molecular mechanism of CD1b antigen presentation
CD1b exhibits the largest and most sophisticated antigen binding groove of all CD1 isoforms. While each member of the CD1 family exhibit an A′ and F′ pocket, CD1b comprises of additional T′ and C′ pockets that are broadly interconnected; where the A′ and F′ pockets are linked by the T′ through the base of the antigen binding groove (Gadola et al., 2002) . From a structural perspective, more is known about the molecular mechanisms of antigen presentation by CD1b compared to the other members of Group 1 CD1s. To date, 11 crystal structures of human CD1b have been deposited onto the Protein Data Bank (PDB), either as a CD1b-lipid or CD1b-lipid-TCR complex structures, with 7 crystal structures determined of CD1b presenting self-lipids (Fig. 2) . The antigens presented by CD1b in these crystal structures are diacyl phospholipids (PI, PC, PG, PA, PS) (Gadola et al., 2002; Garcia-Alles et al., 2006; Shahine et al., 2017) , and ganglioside GM2 (Gadola et al., 2002) (Table 1, Fig. 2 ). The substantial number of crystal structures determined of CD1b presenting self-lipids allows an in-depth analysis on the intricacies of antigen presentation by CD1b, and provides a basis for further understanding the antigen binding groove architecture.
Presented antigen lipid anchors in the A′ and C′ pockets
The acyl-tail configuration is similar within each of the crystal structures of CD1b solved with a phospholipid antigen, where the sn1 and sn2 acyl tails are bound within the C′ and A′ portals respectively (Fig. 2) . Similarly, the shorter acyl tail of GM2 is bound within the C′ pocket, and the longer sphingosine unit bound in the A′ pocket (Table 1 ). The mechanisms of CD1b presentation of each of these lipids are highly comparable, where extensive hydrophobic interactions are made between CD1b and the lipid tails, permitting solvent exposure escape through the F′ portal of the polar headgroups (Fig. 2) . As a result, minimal contacts are made with the polar headgroups of the presented lipids, allowing for TCR interaction and remodelling (Gras et al., 2016; Shahine et al., 2017) . Since all of the structural characterization has been conducted on two tailed self-lipids, structural information on the presentation of lyso-lipids is lacking, despite emerging evidence demonstrating CD1b presentation and T cell activation (Bagchi et al., 2016 (Bagchi et al., , 2017 .
C′ closed conformation limits lipid tail lengths
The C′ portal is a unique feature to CD1b, extending from the F′ portal opening towards the base of the α2 helix, with structural characterization shown to accommodate a lipid antigen tail in each of the structures solved. In these structures, the shorter sn1 tail is bound within the C′ pocket, and accommodates, on average, lipid tails exhibiting 16 carbons (Table 1) . In its closed conformation, where exit through the base of the α2 helix is blocked by large, aliphatic amino acids, there is a limitation in the lipid tail lengths accommodated in the C′ pocket, in a similar manner the A′ pocket of CD1a is described as a "molecular ruler" (Zajonc et al., 2003) . This data may be skewed as a result of the use of self-lipids with defined lipid tail lengths, however in the case of CD1b-PC and CD1b-PG, the crystal structures were determined after loading with a lipid mixture; where the presented PC and PG antigens arose through either endogenous expression (Garcia-Alles et al., 2006), or from bacterial extract respectively. In both cases, the sn1 tail are 16 carbons in length, which coincides with average sn1 tail length within the CD1b crystal structures (Table 1) , with defined lipid species confirmed through mass spectroscopy (Garcia-Alles et al., 2006; Shahine et al., 2017) , suggesting a preferential length for presented self-antigens bound in the C′ pocket.
In each of the CD1b crystal structures, the C′ portal is in a closed conformation, limiting the length of bound lipid tail. The exceptions lie in the crystal structures of CD1b-PI and CD1b-GMM C60, where the amino acid residues at the base of the C′ pocket are more loosely interconnecting, resulting in a solvent exposed opening (Gadola et al., 2002; Batuwangala et al., 2004) . There is speculation that, to accommodate lipid antigens after antigen recycling that exhibit longer lipid tails such as mycolic acids (Gadola et al., 2002; Batuwangala et al., 2004) , the lipid tail escapes through the C′ portal opening; however, this is yet to be demonstrated experimentally. With regards to self-lipids, it is not yet known whether larger endogenous lipids can be accommodated, or even escape, through the C′ portal, as larger endogenous lipids are uncommon in mammalian cells (Huang et al., 2011; Ly and Moody, 2014) ; however extensive lipid elution studies on the endogenous CD1 lipid repertoire are not yet available.
Scaffold lipids maintain structural integrity of CD1b
Despite the ability to present large lipid antigens 60-80 carbons in length, all structural characterization of CD1b exhibit bound self-lipids of 32-35 carbons in length (Table 1, Fig. 2 ). This contrasts with other CD1 molecules; where crystals structures reveal lipids of similar size spanning then entirety of their respective antigen binding grooves. As the hydrophobic cleft of CD1b is larger in volume, this represents a size discrepancy between bound endogenous lipid antigens, and the groove volume . CD1b has the capacity to bind two or more lipids simultaneously, both endogenous lipids, as well as a scaffold lipid, which can be recycled to accommodate a single large microbial lipid .
The lipid tails of presented antigen in each of the CD1b-lipid crystal structures solved are bound within the A′ and C′ pockets, with spacer or scaffold lipids bound within the remaining T′ and F′ pockets. This oddity is unique to CD1b, and gives rise to a two-compartment system of antigen presentation (van Rhijn et al., 2014; Ly and Moody, 2014) , where, in the absence of a lipid antigen that fills the entirety of the antigen binding groove, both a presented self-antigen and scaffold lipid (s) are observed. While scaffold or spacer lipids are present CD1 structures, only in CD1b do they appear to be prevalent throughout all crystal structures currently determined, signifying their essentiality. While the exact roles of scaffold lipids are yet to be elucidated, they seem to primarily maintain the architectural integrity of the CD1b antigen binding cleft in the absence of large lipid antigens.
By looking at a breakdown of lipid distribution across each CD1b pocket, the T′ pocket can accommodate ∼ 23 carbons on average (Table 1) , making it the largest pocket within CD1b; as it traverses the base of the antigen binding cleft, connecting both the A′ and F′ pockets. In each structure, a scaffold lipid is present within the entirety of the T′ pocket (Fig. 2) . The only example where this is not observed is in the crystal structure of CD1b presenting the foreign TB antigen, GMM C60; where its meromycolate tail traverses the A′, T′, and F′ portals, filling the entirety of the antigen binding groove (Batuwangala et al., 2004) (Fig. 2) .
Early structural determination of CD1b was conducted using recombinant protein refolded in the presence of lipid and detergent, and in the crystal structures of CD1b-PI and CD1b-GM2, two detergent molecules represented as hydrocarbon chains are observed in the T′ and F′ pockets (Gadola et al., 2002) (Table 1, Figs. 1 and 2) . Later, mass spectroscopy elution studies on eukaryotically expressed CD1b reveal the presence of a single tail wax ester, of varying saturation and carbon tail length, and can be characterized as a fatty acid esterified to a long tail alcohol (Garcia-Alles et al., 2006) (Table 1, Fig. 1, Fig. 2 ). This 40 carbon wax ester was first observed in the crystal structure of CD1b presenting endogenously expressed PC (Garcia-Alles et al., 2006) , and traverses both T′ and F′ portals (Fig. 2) . Further mass spectroscopy elution studies have identified both deoxyceramides and diacylglycerol (DAG) molecules as scaffold lipids (Garcia-Alles et al., 2011a,b; Huang et al., 2011) (Fig.1) , with DAG found to additionally play a critical role in T-cell activation in the presence of target antigen (Huang et al., 2011) . In many cases where the identity of these scaffold lipids is unknown due to lack of mass spectroscopic analysis, or if features of defined scaffold lipids are poorly defined in the electron density, hydrocarbon chains are built into the T′ and F′ pockets in the absence of a defined scaffold lipid (Gadola et al., 2002; Garcia-Alles et al., 2011b) (Table 1, Fig. 2 ).
These aforementioned scaffold lipids are highly hydrophobic, and lack the polar headgroup found in the presented antigen (Fig. 1) , which allow them to bind deep within the antigen binding groove. This functions not only to stabilize the CD1b molecule, but allow proper formation of the antigen binding groove to allow for correct presentation of the target antigen bound within the A′ and C′ portals to T-cells. Based on the strong electron density observed in the T′ and F′ pockets (Gadola et al., 2002; Garcia-Alles et al., 2006; Shahine et al., 2017) , these scaffold lipids are highly stabilized through a network of hydrophobic interactions deep within the antigen binding groove. However, changes to antigen lipid tail placement in the A′ and C′ pockets have the potential to influence the subsequent position of the scaffold lipid in the T′ pocket. Antigen remodelling upon binding of the CD1b-PG reactive TCR, PG90, onto CD1b presenting PG alters the placement of the lipid tails within the antigen binding groove, resulting in a shift of the scaffold lipid position . This maintains the necessary hydrophobic interactions with the bound lipids to prevent collapse of the antigen binding groove.
As determined by mass spectroscopy and structural determination, a range of scaffold lipid species with varying number of carbons can be observed in CD1b; which appears to depend on the size of the presented lipid antigen, scaffold lipid source, or whether or not a TCR is bound (Table 1, Fig. 2) . Furthermore, the size or species of the bound scaffold could influence selectivity of the presented lipid with defined lipid anchor lengths; as observed from the loading of PC and PG from a mixed source. This suggests a symbiotic relationship between both the presented antigen, and the scaffold lipid, as being vital for maintaining structural integrity of the CD1, and for correct antigen presentation.
The lipid loading conditions used for determining a number of these structures expose CD1b to acidic pH and/or detergent in vitro in the Side view of CD1b antigen binding clefts, represented as ribbons, presenting self-phospholipid (green), self-ganglioside (pink), bacterial (orange), and scaffold (black) lipids, represented as spheres. Oxygen, nitrogen, sulphur, and phosphate are represented in red, blue, yellow, and dark orange respectively. The CD1b pockets, labelled as A′ C′, F′, and T′, as well as the α1 and α2 helices, are indicated in the top left structure (Phosphatidylinositol C33), with labels consistent for each CD1b structure. The antigen binding grooves are represented as surfaces, colored as above, as calculated for each structure using the CASTp 3.0 server (Dundas et al., 2006) using a probe radii of 1.7 Å.
presence of the target antigen only (Gras et al., 2016; Shahine et al., 2017) (Table 1) , as to mimic the in vivo mechanism of antigen loading in the late endosomal-lysosomal pathway. Biologically, this suggests that these scaffold lipids are bound to CD1b upon translation from the endoplasmic reticulum, and may require the presence of lipid loading complexes in the endocytic pathway, such as saposin C, previously shown to be the dominant saposin that facilitates antigen presentation in CD1b (Winau et al., 2004; León et al., 2012) , to assist in the recycling of both endogenous and scaffold lipids in this pathway.
Variability in the F′ pocket
Scaffold lipid presence in the F′ portal displays the greatest variability based on lipid lengths compared to each of the CD1b pockets. On average, 12 carbons can be accommodated in the F′ pocket, and can range from 10 units , to 14 units (Garcia-Alles et al., 2006) ( Table 1, Fig. 2 ). In contrast, the F′ pocket is the only pocket that can be left empty, where no scaffold lipid is present in the CD1b-PG upon complexation with TCR (Table 1, Fig. 2 ). Despite this, the F′ pocket retains its structural integrity through the rearrangement of key buried hydrophobic residues, and the capping of the portal opening via interconnected hydrogen bonds between the α1 and α2 helices ). This capping above the F′ pocket exists in both structures CD1b-PG structures, and provides an additional platform for TCR contact . In comparison, the lack of scaffold lipid in the case of the CD1b-GMM C36 crystal structures alters the architecture of the F′ pocket, where the hydrophobic residues that line the F′ pocket, as well as the F′ cap, are altered; effectively reducing F′ pocket cavity size (Gras et al., 2016) (Fig. 2) .
On the other hand, this cap can be disrupted in the presence of a scaffold lipid that extends beyond the F′ pocket. These scaffold lipids escape through the F′ portal, and are locked between the α1 and α2 helices, which may provide an additional platform for TCR contact. This is observed in the self-lipid crystal structures, aside from the CD1b-PG structure, where the scaffold lipids extend by approximately 5 carbons through the F′ portal, towards the polar headgroup of the presented antigen (Fig. 2) . In comparison, the meromycolate group of the C60 GMM bound to CD1b remains buried (Batuwangala et al., 2004) . Escape through the F′ cap may provide a basis for how CD1b can accommodate TB mycolic acids larger than the C60 GMM present in the crystal structure, however the structural information for this, as well as whether or not scaffold lipid escape aids in the T cell recognition of CD1b, have not presently been defined.
T cell recognition of CD1 molecules presenting self-lipids
Since the determination of the first co-complexation crystal structure of a CD1d in complex with an iNKT TCR (Borg et al., 2007) , a majority of the focus in the field has been on characterizing the molecular mechanisms of human or mouse CD1d antigen presentation, and TCR recognition . In contrast, our understanding of Group 1 CD1 recognition by their respective restricted TCRs are significantly limited. However, recent advances upon the structural determination of αβ TCRs in complex with both CD1b and CD1c (Wun et al., 2018) presenting self-lipids have greatly improved our understanding in the molecular mechanisms of TCR docking onto Group 1 CD1s. Namely, we now have a model describing the mechanisms of each CD1 molecule presenting self-lipids in complex with their respective restricted αβ TCR (Fig. 3) .
These co-complexation crystal structures reveal the inter-molecular intricacies of CD1-TCR interaction. However, the mechanisms of TCR docking, involvement of lipid antigen interaction, and molecular remodelling differ across each CD1 isoform, with each mode grouped into two broad categories: TCR co-recognition of CD1-lipid antigen, and the "absence of interference" model. A. Shahine Molecular Immunology 104 (2018) 27-36 5.1. Co-recognition of the CD1-self lipid complex
The first crystal structure of an αβ TCR in complex with CD1b presenting a self-lipid was recently determined, where it exhibited a corecognition model of docking; in that the CD1b-restricted TCR, PG90, contacts both the CD1b and the presented antigen, PG, in a highly specific manner . Of the total buried surface area between this interaction, approximately 24% of the BSA is contributed by TCR contact with the antigen headgroup (Cotton et al., 2018) . Here, the PG90 TCR moulds over phosphoglycerol headgroup moiety and completely sequesters it in a highly specific manner (Fig. 3) . This docking mechanism is highly reminiscent of the crystal structure of the germline-encoded mycolyl-lipid reactive TCR, GEM42, in complex with CD1b presenting the TB lipid GMM (Gras et al., 2016) . In both cases, the CDR3 regions act as highly specific molecular "tweezers" sequester the solvent exposed polar headgroups of their respective antigens in a highly antigen specific manner.
While the mechanisms differ, this mode is highly reminiscent of the co-recognition mechanism of docking between CD1d and iNKT TCRs. While extensive structural characterization on mouse or human CD1d has been conducted against the presentation and iNKT TCR recognition of marine-sponge derived antigen α-Galactosylceramide (α-GalCer), (Reviewed in Godfrey et al., 2015; Rossjohn et al., 2015) , further investigation into the role of self-lipid antigen presentation implicates a role in autoimmunity, autoreactivity, and cancer (Wilson and Delovitch, 2003; Brigl and Brenner, 2004; Van Kaer, 2005; Bendelac et al., 2007) Structures of CD1d presenting phospholipids PI (Fig. 3) and LPC (Lopez-Sagaseta et al., 2012) , as well as glycolipid isoglobotrihexosylceramide (iGB3) (Yu et al., 2011; Pellicci et al., 2011) , have been determined in complex with αβ Type 1 invariant NKT TCRs. Furthermore, structural characterization into the interactions between αβ Type II iNKT TCRs against CD1d presenting sulfatide (Fig. 3) (Patel et al., 2012) , and lyso-sulfatide have also been determined. Despite the differences in self-lipid species, size, and NKT cell function in the innate and adaptive immunity systems, these crystal structures reveal similarities in mechanisms of co-recognition of both a solvent-exposed antigen headgroup, and specificity towards CD1d (Fig. 3) . Differences lie in the docking angles, and preferential docking on CD1d over the A′ pocket (Type II NKT TCR), or the F′ pocket (Type I NKT TCR), as well as role in the germline encoded residues for CD1d-lipid contacts (Fig. 3 ), however this model of co-recognition appears to be a critical mechanism for TCR recognition of CD1d, and know a similar mechanism is observed for CD1b. Fig. 3 . Models of TCR recognition of CD1 molecules presenting self-lipids. The mechanisms of TCR recognition of CD1 molecules can be split into two broad groups: Co-recognition of CD1 and lipid antigen (left), and the absence of interference model (right). Side view of the CD1-TCR co-complexation crystal structures determined between CD1a (blue), CD1b (green), CD1c (orange), and CD1d (cyan), in complex with their respective restricted TCRs. TCR α-chain and β-chain variable (vα/vβ) and constant (cα/cβ) domains are colored pink and yellow respectively. B) Close up view of the contact interface between TCR α-chain (pink), β-chain (yellow), CD1a (blue), CD1b (green), CD1c (orange), and CD1d (cyan). Both TCRs and CD1 molecules are represented as surfaces. Antigens phosphatidylglycerol (PG), phosphatidylinositol (PI), Sulfatide, lysophosphatidylcholine (LPC), monoacylglycerol (MAG), and spacer lipids are represented as black spheres, with contacted antigen atoms, as well as TCR residues involved in antigen contacts, colored in red.
Absence of interference model
The recently determined crystal structure of both CD1b and CD1c presenting self-lipids in complex with an αβ TCR allow a direct comparison between the molecular mechanisms of αβ TCR recognition of Group 1 CD1s presenting self-lipids. TCR docking onto CD1b stands alone compared to TCR docking onto CD1a and CD1c, which rely on an "absence of interference" model centred around permissive, buried lipids to permit TCR recognition (Birkinshaw et al., 2015; Wun et al., 2018) (Fig. 3) . The two complex crystal structures of CD1a in complex with the BK6 TCR, and the recently determined structure of CD1c in complex with the 3C8 TCR, all demonstrate respective Group 1 CD1 recognition independent of lipid contacts, via differing mechanisms.
In each case, the BK6 and 3C8 TCRs contact the CD1 A′ roof, the closed surface formed through interconnecting interactions between the α1 and α2 helices above the A′ pocket, with no contact towards the presented lipids. While the 3C8 TCR docks centrally over the F′ portal of CD1c, with the TCR α and β chains making equivalent contacts over the A′ and F′ pockets respectively, the BK6 TCR docks via a "left-right mismatch" mechanism: where TCR docking is left shifted over the A′ roof, and the polar headgroup of the presented LPC lipid can escape via the far right marginal F′ portal opening (Birkinshaw et al., 2015; Wun et al., 2018) (Fig. 3) . While CD1a and CD1c present additional buried antigens, such self-lysophospholipids (Roy et al., 2016) and the poison ivy active agent urishiol (Kim et al., 2016) , to T cells, it is presently unclear whether or not TCR docking upon presentation of lipids with larger polar headgroups, including self-sulfatides or mycobacterial mycoketides (Scharf et al., 2010; Roy et al., 2014) , will occur via the absence of interference model. For CD1a and CD1c, TCR recognition is dependent on the presentation of buried "permissive" ligands, where larger, solvent exposed "non-permissive" antigens. Presentation of sphingomyelin by CD1a has been shown to disrupt correct formation of the A′ roof, preventing correct TCR docking by this mechanism, thus potentially nullifying the absence of interference model (Birkinshaw et al., 2015) . In the case of antigen presentation by CD1b, the solvent exposed polar headgroup is critical for CD1b-restricted TCR recognition. While unique for group 1 CD1 molecules, the co-recognition model fits with both Type I and Type II iNKT TCR recognition of CD1d presenting self-lipids, where this mode of interaction results in a highly specific interaction. It is still yet to be determined whether there are exceptions to these general mechanistic models of docking, with characterization of group 1 CD1 -TCR interactions restricted to a limited sample of successfully determined ternary crystal structures.
Conclusion
Herein, we have taken a closer look at the recent advances in unravelling the molecular mechanisms of self-lipid presentation by CD1b. CD1b has the capacity to bind and present a wide array of self-phospholipids and sphingolipids (Fig. 1) , on the cell surface of APCs; with implicit implications in microbial, autoimmune, or cancerous disease states. As a substantial number of crystal structures of CD1b presenting self-lipids have been determined, we have a clearer understanding of how the two-compartment system of CD1b antigen presentation functions, and are able to delve deeper into the characterization of the symbiotic relationship between the self-lipid presented antigen, and scaffold lipids (Table 1, Fig. 2 ). These have a significant impact on T cell recognition, as the exposed polar headgroup of presented lipid antigens by CD1b are specifically recognized by the TCR via a co-recognition mode of docking (Fig. 3) . On the other hand, we have barely scratched the surface in elucidating the genetic and immunological mechanisms that tightly regulate CD1 expression, maturation of CD1 + APCs, and the subsequent downstream processed that govern positive thymic selection of CD1b-restricted autoreactive T cells. Yet despite these current drawbacks, it is clear that future functional and structural work will further increase our understanding into the role of self-lipid presentation by CD1b in disease.
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